1-3 of 3
Max Jan
Close
Sort by
Journal Articles

Clonal hematopoiesis in patients receiving chimeric antigen receptor T-cell therapy

Peter G. Miller, Adam S. Sperling, Elliott J. Brea, Mark B. Leick, Geoffrey G. Fell, Max Jan, Satyen H. Gohil, Yu-Tzu Tai, Nikhil C. Munshi, Catherine J. Wu, Donna S. Neuberg, Marcela V. Maus, Caron Jacobson, Christopher J. Gibson, Benjamin L. Ebert
Journal: Blood Advances
Blood Adv (2021) 5 (15): 2982–2986.
https://doi.org/10.1182/bloodadvances.2021004554
Published: 2021
Includes: Supplemental data
Journal Articles

A cryptic imatinib-sensitive G3BP1-PDGFRB rearrangement in a myeloid neoplasm with eosinophilia

Clinical Trials & Observations
Max Jan, Daniel E. Grinshpun, Julian A. Villalba, Paola Dal Cin, David B. Sykes, A. John Iafrate, Benjamin L. Ebert, Gabriela S. Hobbs, Valentina Nardi
Journal: Blood Advances
Blood Adv (2020) 4 (3): 445–448.
https://doi.org/10.1182/bloodadvances.2019001182
Published: 2020
Journal Articles

Recurrent genetic HLA loss in AML relapsed after matched unrelated allogeneic hematopoietic cell transplantation

Clinical Trials & Observations
Max Jan, Matthew J. Leventhal, Elizabeth A. Morgan, Jordan C. Wengrod, Anwesha Nag, Samantha D. Drinan, Bruce M. Wollison, Matthew D. Ducar, Aaron R. Thorner, Scott Leppanen, Jane Baronas, Jonathan Stevens, William J. Lane, Natasha Kekre, Vincent T. Ho, John Koreth, Corey S. Cutler, Sarah Nikiforow, Edwin P. Alyea, III, Joseph H. Antin, Robert J. Soiffer, Jerome Ritz, R. Coleman Lindsley, Benjamin L. Ebert
Journal: Blood Advances
Blood Adv (2019) 3 (14): 2199–2204.
https://doi.org/10.1182/bloodadvances.2019000445
Published: 2019
Includes: Supplemental data